Vertex Pharmaceuticals
Search results
Jun 26, 2024 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Reach out for information about our products and services or get answers to questions about our technology. *For in vitro diagnostic use. Contact an Illumina representative for regional availability. Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.
A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome.
Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. "The addition of Fluent BioSciences to Illumina will provide significant and new capabilities to our customers in a key growth area and advances our multiomics ...
Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and ...
From cancer research to prenatal screening to food safety, the applications are as universal as life itself. Learn More. Our goal is to transform human health by applying innovative genomics technologies to the analysis of genetic variation and function.
Jan 10, 2022 · January 10, 2022. Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally.
This detailed overview of Illumina sequencing describes the evolution of genomic science, major advances in sequencing technology, key methods, the basics of Illumina sequencing chemistry, and more. Read Introduction
At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.
